Reviva Pharmaceuticals Holdings (RVPH) Operating Expenses (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Operating Expenses of $3.3 million for Q1 2026, down 8.07% sequentially from $3.6 million in Q4 2025, and down 49.96% YoY from $6.5 million in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Operating Expenses (2018 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Operating Expenses for 9 years, with the latest figure at $3.3 million in Q1 2026.
- Quarterly Operating Expenses fell 49.96% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (down 42.43% YoY) and the FY2025 annual result came in at $20.2 million, down 34.41% from the prior year.
- Operating Expenses slipped to $3.3 million in Q1 2026 per RVPH's latest filing, from $3.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $11.6 million in Q3 2023 and troughed at $3.3 million in Q1 2026.
- A 5-year average of $7.1 million and a median of $7.0 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 297.95% in 2022, then slumped 52.38% in 2025.
- Over 5 years, Operating Expenses stood at $8.9 million in 2022, then grew by 8.17% to $9.6 million in 2023, then slumped by 34.67% to $6.3 million in 2024, then plunged by 43.37% to $3.6 million in 2025, then slipped by 8.07% to $3.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $3.3 million, $3.6 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | 6.28 Mn |
| Sep 30, 2024 | 8.46 Mn |
| Jun 30, 2024 | 8.13 Mn |
| Mar 31, 2024 | 7.92 Mn |
| Dec 31, 2023 | 9.62 Mn |
| Sep 30, 2023 | 11.56 Mn |
| Jun 30, 2023 | 11.34 Mn |
| Mar 31, 2023 | 6.98 Mn |
| Dec 31, 2022 | 8.89 Mn |
| Sep 30, 2022 | 5.50 Mn |
| Jun 30, 2022 | 5.52 Mn |
| Mar 31, 2022 | 7.45 Mn |
| Dec 13, 2021 | 3.96 Mn |
| Sep 30, 2021 | 2.48 Mn |